B-MAD chemotherapy
TLSG-2017-T01
Phase 2 small_molecule completed
Quick answer
B-MAD chemotherapy for Extranodal NK/T-cell Lymphoma is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Extranodal NK/T-cell Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed